M&T Bank’s Juno Therapeutics, Inc. JUNO Stock Holding History

M&T Bank’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-14,015	Closed	-$640K	–	1671
2017 Q4	$640K	Buy	14,015 +60	+0.4%	+$2.99K	﹤0.01%	918
2017 Q3	$625K	Buy	13,955 +519	+4%	+$17.7K	﹤0.01%	907
2017 Q2	$402K	Sell	13,436 -3,750	-22%	-$92.5K	﹤0.01%	1069
2017 Q1	$381K	Buy	+17,186	New	+$369K	﹤0.01%	1121
2016 Q2	–	Sell	-6,712	Closed	-$256K	–	1805
2016 Q1	$256K	Sell	6,712 -474	-7%	-$16.5K	﹤0.01%	1353
2015 Q4	$317K	Buy	7,186 +569	+9%	+$28.2K	﹤0.01%	1268
2015 Q3	$269K	Buy	+6,617	New	+$290K	﹤0.01%	1371

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

M&T Bank's JUNO Position: Q1 2018 in Review

M&T Bank sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 14,015 shares — an estimated $640K sold.

M&T Bank first reported a position in JUNO in Q3 2015 and held it in 7 quarters. The position peaked at $640K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

M&T Bank reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
M&T Bank sold 14,015 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $640K.
M&T Bank first reported a position in Juno Therapeutics, Inc. in Q3 2015 and held it in 7 quarters.
M&T Bank's Juno Therapeutics, Inc. position peaked at $640K in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on M&T Bank's 13F filing for Q1 2018, filed 4 May 2018.